Kondor Pharma Inc, is developing and commercializing evidenced-based nutraceuticals for treatment or management of symptoms of neurological disorders. Kondor's current products include three clinically-proven products, Memowell, Strowell, and Genuwell to manage aging-associated conditions caused by chronic inflammation. Kondor Pharma’s headquarter/ R&D facility is located in Mississauga, Canada.